
-
1995
Company Description
Alchemia Limited is a listed Australian biopharmaceutical company with an FDA approved drug and a late stage oncology product.
Alchemia Limited is a listed Australian biopharmaceutical company (ASX:ACL) with an FDA approved drug (Fondaparinux sodium) and a late stage oncology product pipeline derived from the HyACT platform. In addition, Alchemia has a drug discovery platform, VAST, derived from Alchemia’s chemistry expertise.
-
Manufacturer:
Science and Engineering -
Formed:
1995 -
Company Website:
-
Company E-mail:
-
Company Address:
3 Hi-tech Court, Brisbane Technology ParkEight Mile PlainsAustralia -
CEO:
- Charles Walker
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits